{"database": "lobbying", "table": "lobbying_activities", "rows": [[2337736, "3cea46a6-1745-4e1c-a771-faba91fdbdc8", "Q3", "BLOOM STRATEGIC COUNSEL", 401036920, "FRESENIUS MEDICAL CARE NORTH AMERICA", 2019, "third_quarter", "HCR", "Reimbursement methodology for kidney dialysis services", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-01T15:12:18.917000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2337736"], "units": {}, "query_ms": 0.44299999717622995, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}